Epigenetic alteration of DNA in mucosal wash fluid predicts invasiveness of colorectal tumors

Cancer Prevention Research

Volumn 4, Issue 5, 2011, Pages 674-683

  Kamimae, Seiko ^a   Yamamoto, Eiichiro ^a   Yamano, Hiro O ^b   Nojima, Masanori ^a   Suzuki, Hiromu ^a   Ashida, Masami ^a   Hatahira, Tomo ^a   Sato, Akiko ^a   Kimura, Tomoaki ^b   Yoshikawa, Kenjiro ^b   Harada, Taku ^b   Hayashi, Seiko ^b   Takamaru, Hiroyuki ^a   Maruyama, Reo ^a   Kai, Masahiro ^a   Nishiwaki, Morie ^c   Sugai, Tamotsu ^d   Sasaki, Yasushi ^a   Tokino, Takashi ^a   Shinomura, Yasuhisa ^a   Imai, Kohzoh ^e   Toyota, Minoru ^a   more..

^a SAPPORO MEDICAL UNIVERSITY   (Japan)

^b AKITA RED CROSS HOSPITAL   (Japan)

^c GeneticLab Co Ltd   (Japan)

^d IWATE MEDICAL UNIVERSITY   (Japan)

^e UNIVERSITY OF TOKYO   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

DIGESTIVE TRACT AGENT; DNA; K RAS PROTEIN; MOLECULAR MARKER; MUCOSAL WASH FLUID; UNCLASSIFIED DRUG;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; CANCER INVASION; CLINICAL ARTICLE; COLONOSCOPY; COLORECTAL TUMOR; CONTROLLED STUDY; CYTOLOGY; DIAGNOSTIC ACCURACY; DNA METHYLATION; EPIGENETICS; FEMALE; HISTOPATHOLOGY; HUMAN; MALE; MUTATIONAL ANALYSIS; NUCLEOTIDE SEQUENCE; ONCOGENE K RAS; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY; TUMOR BIOPSY; TUMOR CELL; TUMOR LOCALIZATION; TUMOR VOLUME;

AGED; COLORECTAL NEOPLASMS; DNA METHYLATION; DNA, NEOPLASM; EPIGENOMICS; FEMALE; HUMANS; MALE; MICRORNAS; MIDDLE AGED; MUCOUS MEMBRANE; NEOPLASM INVASIVENESS; POLYMERASE CHAIN REACTION;

EID: 79955789096     PISSN: 19406207     EISSN: 19406215     Source Type: Journal    
DOI: 10.1158/1940-6207.CAPR-10-0214     Document Type: Article

References (39)

1. Jemal A, Siegel R, Ward E, Hao Y, Xu J, Murray T, et al. Cancer statistics, 2008. CA Cancer J Clin 2008;58:71-96.
2. Davies RJ, Miller R, Coleman N. Colorectal cancer screening: prospects for molecular stool analysis. Nat Rev Cancer 2005;5:199-209. (Pubitemid 40314951)
3. Osborn NK, Ahlquist DA. Stool screening for colorectal cancer: molecular approaches. Gastroenterology 2005;128:192-206. (Pubitemid 40039970)
4. Kwok H, Bissett IP, Hill GL. Preoperative staging of rectal cancer. Int J Colorectal Dis 2000;15:9-20.
5. Yamada I, Okabe S, Enomoto M, Sugihara K, Yoshino N, Tetsumura A, et al. Colorectal carcinoma: in vitro evaluation with high-spatial-resolution 3D constructive interference in steady-state MR imaging. Radiology 2008;246:444-53.
6. Hurlstone DP, Cross SS, Adam I, Shorthouse AJ, Brown S, Sanders DS, et al. A prospective clinicopathological and endoscopic evaluation of flat and depressed colorectal lesions in the United Kingdom. Am J Gastroenterol 2003;98:2543-9. (Pubitemid 37448769)
7. Kudo S, Kashida H, Tamura T, Kogure E, Imai Y, Yamano H, et al. Colonoscopic diagnosis and management of nonpolypoid early colorectal cancer. World J Surg 2000;24:1081-90.
8. Soetikno R, Friedland S, Kaltenbach T, Chayama K, Tanaka S. Nonpolypoid (flat and depressed) colorectal neoplasms. Gastroenterology 2006;130:566-76; quiz 88-9.
9. Bianco MA, Rotondano G, Marmo R, Garofano ML, Piscopo R, de Gregorio A, et al. Predictive value of magnification chromoendoscopy for diagnosing invasive neoplasia in nonpolypoid colorectal lesions and stratifying patients for endoscopic resection or surgery. Endoscopy 2006;38:470-6. (Pubitemid 43744704)
10. Matsuda T, Fujii T, Saito Y, Nakajima T, Uraoka T, Kobayashi N, et al. Efficacy of the invasive/non-invasive pattern by magnifying chromoendoscopy to estimate the depth of invasion of early colorectal neoplasms. Am J Gastroenterol 2008;103:2700-6.
11. Kanao H, Tanaka S, Oka S, Hirata M, Yoshida S, Chayama K. Narrowband imaging magnification predicts the histology and invasion depth of colorectal tumors. Gastrointest Endosc 2009;69:631-6.
12. Markowitz SD, Bertagnolli MM. Molecular origins of cancer: Molecular basis of colorectal cancer. N Engl J Med 2009;361:2449-60.
13. Wong JJ, Hawkins NJ, Ward RL. Colorectal cancer: a model for epigenetic tumorigenesis. Gut 2007;56:140-8. (Pubitemid 46044900)
14. Issa JP. CpG island methylator phenotype in cancer. Nat Rev Cancer 2004;4:988-93.
15. Jones PA, Baylin SB. The epigenomics of cancer. Cell 2007;128:683-92. (Pubitemid 46273572)
16. Glöckner SC, Dhir M, Yi JM, McGarvey KE, Van Neste L, Louwagie J, et al. Methylation of TFPI2 in stool DNA: a potential novel biomarker for the detection of colorectal cancer. Cancer Res 2009;69:4691-9.
17. Hellebrekers DM, Lentjes MH, van den Bosch SM, Melotte V, Wouters KA, Daenen KL, et al. GATA4 and GATA5 are potential tumor suppressors and biomarkers in colorectal cancer. Clin Cancer Res 2009;15:3990-7.
18. Li M, Chen WD, Papadopoulos N, Goodman SN, Bjerregaard NC, Laurberg S, et al. Sensitive digital quantification of DNA methylation in clinical samples. Nat Biotechnol 2009;27:858-63.
19. Müller HM, Oberwalder M, Fiegl H, Morandell M, Goebel G, Zitt M, et al. Methylation changes in faecal DNA: a marker for colorectal cancer screening? Lancet 2004;363:1283-5.
20. Zou HZ, Yu BM, Wang ZW, Sun JY, Cang H, Gao F, et al. Detection of aberrant p16 methylation in the serum of colorectal cancer patients. Clin Cancer Res 2002;8:188-91. (Pubitemid 34101476)
21. Ahuja N, Li Q, Mohan AL, Baylin SB, Issa JP. Aging and DNA methylation in colorectal mucosa and cancer. Cancer Res 1998;58:5489-94. (Pubitemid 28551135)
22. Issa JP, Ottaviano YL, Celano P, Hamilton SR, Davidson NE, Baylin SB. Methylation of the oestrogen receptor CpG island links ageing and neoplasia in human colon. Nat Genet 1994;7:536-40. (Pubitemid 24308343)
23. Park SJ, Rashid A, Lee JH, Kim SG, Hamilton SR, Wu TT. Frequent CpG island methylation in serrated adenomas of the colorectum. Am J Pathol 2003;162:815-22. (Pubitemid 36237490)
24. Satoh A, Toyota M, Itoh F, Sasaki Y, Suzuki H, Ogi K, et al. Epigenetic inactivation of CHFR and sensitivity to microtubule inhibitors in gastric cancer. Cancer Res 2003;63:8606-13. (Pubitemid 38064034)
25. Toyota M, Suzuki H, Sasaki Y, Maruyama R, Imai K, Shinomura Y, et al. Epigenetic silencing of microRNA-34b/c and B-cell translocation gene 4 is associated with CpG island methylation in colorectal cancer. Cancer Res 2008;68:4123-32.
26. Kusano M, Toyota M, Suzuki H, Akino K, Aoki F, Fujita M, et al. Genetic, epigenetic, and clinicopathologic features of gastric carcinomas with the CpG island methylator phenotype and an association with Epstein-Barr virus. Cancer 2006;106:1467-79.
27. Sato H, Suzuki H, Toyota M, Nojima M, Maruyama R, Sasaki S, et al. Frequent epigenetic inactivation of DICKKOPF family genes in human gastrointestinal tumors. Carcinogenesis 2007;28:2459-66. (Pubitemid 350238947)
28. Suzuki H, Watkins DN, Jair KW, Schuebel KE, Markowitz SD, Chen WD, et al. Epigenetic inactivation of SFRP genes allows constitutive WNT signaling in colorectal cancer. Nat Genet 2004;36:417-22. (Pubitemid 38437267)
29. Tanaka S, Kaltenbach T, Chayama K, Soetikno R. High-magnification colonoscopy (with videos). Gastrointest Endosc 2006;64:604-13. (Pubitemid 44419411)
30. Winawer SJ, Zauber AG, Fletcher RH, Stillman JS, O'Brien MJ, Levin B, et al. Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. Gastroenterology 2006;130:1872-85.
31. Matsubayashi H, Canto M, Sato N, Klein A, Abe T, Yamashita K, et al. DNA methylation alterations in the pancreatic juice of patients with suspected pancreatic disease. Cancer Res 2006;66:1208-17. (Pubitemid 43165992)
32. Pattani KM, Zhang Z, Demokan S, Glazer C, Loyo M, Goodman S, et al. Endothelin receptor type B gene promoter hypermethylation in salivary rinses is independently associated with risk of oral cavity cancer and premalignancy. Cancer Prev Res 2010;3:1093-103.
33. Watanabe Y, Kim HS, Castoro RJ, Chung W, Estecio MR, Kondo K, et al. Sensitive and specific detection of early gastric cancer with DNA methylation analysis of gastric washes. Gastroenterology 2009;136:2149-58.
34. Shen L, Toyota M, Kondo Y, Lin E, Zhang L, Guo Y, et al. Integrated genetic and epigenetic analysis identifies three different subclasses of colon cancer. Proc Natl Acad Sci U S A 2007;104:18654-9. (Pubitemid 350210752)
35. He L, He X, Lim LP, de Stanchina E, Xuan Z, Liang Y, et al. A microRNA component of the p53 tumour suppressor network. Nature 2007;447:1130-4. (Pubitemid 47014436)
36. White V, Scarpini C, Barbosa-Morais NL, Ikelle E, Carter S, Laskey RA, et al. Isolation of stool-derived mucus provides a high yield of colonocytes suitable for early detection of colorectal carcinoma. Cancer Epidemiol Biomarkers Prev 2009;18:2006-13.
37. Zhao C, Ivanov I, Dougherty ER, Hartman TJ, Lanza E, Bobe G, et al. Noninvasive detection of candidate molecular biomarkers in subjects with a history of insulin resistance and colorectal adenomas. Cancer Prev Res 2009;2:590-7.
38. Brown JM, Attardi LD. The role of apoptosis in cancer development and treatment response. Nat Rev Cancer 2005;5:231-7. (Pubitemid 40314954)
39. Christofori G. Changing neighbours, changing behaviour: cell adhesion molecule-mediated signalling during tumour progression. EMBO J 2003;22:2318-23. (Pubitemid 36604971)